Familial C3 glomerulonephritis associated with mutations in the gene for complement factor B
Hideaki Imamura1, Takao Konomoto1, Etsuko Tanaka2
1Division of Pediatrics, Department of Reproductive and Developmental Medicine, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center, Osaka, Japan.
Insights
Familial C3 glomerulonephritis (C3GN) is linked to complement factor B (CFB) gene mutations. This discovery offers new avenues for anticomplement therapies in treating kidney disease.
Area of Science:
- Nephrology
- Genetics
- Immunology
Background:
- C3 glomerulonephritis (C3GN) is a rare kidney disease characterized by complement system dysregulation.
- Familial cases of C3GN suggest a genetic predisposition, but specific causative genes remain largely unidentified.
Observation:
- A 12-year-old girl presented with biopsy-proven C3GN.
- Her family history revealed a mother treated for membranoproliferative glomerulonephritis and a brother with hypocomplementemia.
- Genetic analysis identified a novel mutation in the complement factor B (CFB) gene (p.S367R) in all affected family members.
Findings:
- The identified CFB p.S367R mutation was found to have gain-of-function effects.
- This mutation is associated with the development of C3GN in a familial context.
- The study establishes a direct link between CFB mutations and C3GN pathogenesis.
Implications:
- Complement factor B (CFB) plays a critical role in the etiology of C3GN.
- This finding provides a new genetic basis for understanding familial C3GN.
- The results offer novel insights for developing targeted anticomplement therapies for C3GN and related kidney disorders.
Abstract:
We report the first case of familial C3 glomerulonephritis (C3GN) associated with mutations in the gene for complement factor B (CFB). A 12-year-old girl was diagnosed with biopsy-proven C3GN. Her mother had a history of treatment for membranoproliferative glomerulonephritis, and her brother had hypocomplementemia without urinary abnormalities. DNA analysis revealed heterozygosity for CFB p.S367R in the patient, mother and brother. Evaluation of the structure-function relationship supports that this mutation has gain-of-function effects in CFB. The present case suggests that CFB has an important role in the etiology of C3GN and provides a new insight into anticomplement therapy approaches.
Related Concept Videos
Complement System
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Mutations
Cytomegalovirus Disease
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypersensitivity Reactions: Immune-Complex Reactions


